Skip to main content

Emerphed FDA Approval History

Last updated by Judith Stewart, BPharm on June 24, 2020.

FDA Approved: Yes (First approved April 17, 2020)
Brand name: Emerphed
Generic name: ephedrine sulfate
Dosage form: Injection
Company: Nexus Pharmaceuticals, Inc.
Treatment for: Hypotension

Emerphed (ephedrine sulfate) is a ready-to-use formulation of the approved pressor agent ephedrine indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

Development timeline for Emerphed

Apr 21, 2020Approval FDA Approves Emerphed (ephedrine sulfate) Ready-to-Use Injection for Hypotension During Anesthesia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.